Today: 29 April 2026
Browse Category

ASX:SHL 2 February 2026 - 19 February 2026

Sonic Healthcare stock jumps nearly 10% after profit lift, dividend hike, guidance held

Sonic Healthcare stock jumps nearly 10% after profit lift, dividend hike, guidance held

Sonic Healthcare shares jumped 9.9% to A$23.34 after half-year net profit rose 11% to A$262 million and revenue climbed 17% to A$5.45 billion. The company raised its interim dividend to 45 Australian cents, with the stock set to trade ex-dividend on March 4. Full-year earnings guidance was maintained. Management flagged a review of U.S. operations and a planned A$450–500 million sale-and-leaseback of its Brisbane lab.
19 February 2026
··

Stock Market Today

  • Oil Prices Surge as U.S. Plans to Extend Hormuz Strait Blockade, Tightening Global Market
    April 29, 2026, 9:54 AM EDT. Oil prices jumped sharply on Wednesday amid reports the White House intends to continue the U.S. naval blockade of the Strait of Hormuz indefinitely, a crucial global energy passage. Brent crude futures rose about 3.3% above $114 per barrel, while U.S. West Texas Intermediate crude climbed 3.4% to around $103. The blockade aims to pressure Iran by restricting oil flow, exacerbating an already tight market with a nearly 14 million barrel-per-day shortfall in April, per Goldman Sachs. With Iran's oil storage nearing capacity and production risks rising, the standoff threatens further supply constraints. President Trump insists the blockade will stay until Iran agrees to a deal, intensifying tensions and leaving global oil inventories near all-time lows.

Latest article

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

29 April 2026
Lemonade Inc reported first-quarter revenue of $258 million, up 71% from a year earlier, and narrowed its net loss to $35.8 million, or 47 cents a share. Shares rose 5.6% in premarket trading after results beat estimates. In-force premium climbed 32% to $1.33 billion, with customers up 23% to 3.14 million. The company raised its 2026 outlook and now expects full-year revenue of up to $1.203 billion.
Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Go toTop